✦ LIBER ✦

EGFR CA repeat polymorphism predict clinical outcome in EGFR mutation positive NSCLC patients treated with erlotinib

✍ Scribed by Winther Larsen, Anne; Nissen, Peter Henrik; Meldgaard, Peter; Weber, Britta; Sorensen, Boe Sandahl

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

414 Correlation of mutations in EGFR wit

✍ D. Eberhard; L. Amler; A. Goddard; W. Ince; T. Januario; K. Hillan; M. Ostland; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB

24 Outcome in metastatic NSCLC without E

✍ Dua, D.; Montes, A.; Warner, M.; Spicer, J.; Lal, R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9154 Clinical outcomes in patients with

✍ Paz-Ares, L.; Soulières, D.; Klughammer, B.; Melezínek, I.; Moecks, J.; Keil, L. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Is there any predictor for clinical outc

✍ Lee, Ji Yun; Lim, Sung Hee; Kim, Moonjin; Kim, Sungmin; Jung, Hyun Ae; Chang, Wo 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 258 KB

27 Risk of CNS progression in EGFR mutat

✍ Walter, H.S.; Plant, R.; Chauhan, M.; Fennell, D.A.; Ahmed, S.I. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 45 KB

196 POSTER Intron 1 CA repeat polymorphi

✍ J.Y. Shin; J.O. Kim; S.J. Lim; H.S. Won; T.H. Kim; C.H. Lee; M.S. Kim; J.H. Kang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB